Detalhe da pesquisa
1.
Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
Bioorg Med Chem Lett
; 20(4): 1388-94, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20097563
2.
Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
Bioorg Med Chem Lett
; 19(16): 4657-63, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604694
3.
Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
Bioorg Med Chem Lett
; 19(21): 6148-56, 2009 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19796941
4.
Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
J Med Chem
; 53(5): 2010-37, 2010 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20141147
5.
Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.
J Lipid Res
; 44(9): 1614-21, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810816